Loading...
Loading...
India accounts for a significant share of global Soframycin exports, with 63+ registered manufacturers shipping to buyers across 36+ countries — yet a handful of companies dominate the shipments. ENCUBE ETHICALS PRIVATE LIMITED holds the largest share at 79.0% (export value: $473.2K). Close behind, CAPSTONE EXPORT & IMPORT (11.7%, $70.0K). S. HIMATLAL HEALTHCARE LLP (3.1%, $18.5K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
Comprehensive supplier network intelligence dashboard
Flow of Soframycin from leading Indian exporters to their key global customers
Top Suppliers → Customer Networks
The Soframycin export market from India is led by ENCUBE ETHICALS PRIVATE LIMITED, which alone commands a 79.0% share, shipping $473.2K worth of product across 19 shipments. The second-largest exporter, CAPSTONE EXPORT & IMPORT, contributes $70.0K (11.7%) to the overall market. Combined, the top two suppliers alone account for 90.7% of all Soframycin exports, indicating a relatively concentrated supply base.
Across all 63 tracked manufacturers, the total Soframycin export value stands at $598.8K from 243 shipments. The market average shipment value is $2.5K. The single largest buyer relationship in terms of trade value is A. BAUR & CO. (PVT.) LTD, receiving $208.0K worth of product.
The combined buyer network spans 7 named purchasing companies, including A. BAUR & CO. (PVT.) LTD, A BAUR CO PRIVATE LIMITED, A BAUR AND CO PVT LTD, PRINCE FARMA SA, VMK MEDICAL ENTERPRISES and 2 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
ENCUBE ETHICALS PRIVATE LIMITED is the first-largest Soframycin exporter from India, with a market share of 79.0% and a total export value of $473.2K across 19 shipments. Their average shipment value of $24.9K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
ENCUBE ETHICALS PRIVATE LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• A. BAUR & CO. (PVT.) LTD — $208.0K across 8 shipments (44.0% of this supplier's total exports)
• A BAUR CO PRIVATE LIMITED — $168.8K across 7 shipments (35.7% of this supplier's total exports)
• A BAUR AND CO PVT LTD — $96.4K across 4 shipments (20.4% of this supplier's total exports)
Key Insight: ENCUBE ETHICALS PRIVATE LIMITED's per-shipment value of $24.9K is 911% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
CAPSTONE EXPORT & IMPORT is the second-largest Soframycin exporter from India, with a market share of 11.7% and a total export value of $70.0K across 10 shipments. Their average shipment value of $7.0K is above the market average of $2.5K, suggesting .
Once Soframycin leaves the manufacturing plants of companies like ENCUBE ETHICALS PRIVATE LIMITED and CAPSTONE EXPORT & IMPORT, it travels to 5 destination markets with a combined import value of $598.8K. Sri Lanka absorbs the largest share at 79.0% ($473.2K), followed by Angola (11.7%) and Tanzania (3.9%).
In Sri Lanka — the top destination — named importers include A. BAUR & CO. (PVT.) LTD, A BAUR CO PRIVATE LIMITED, A BAUR AND CO PVT LTD. In Angola, key buyers are PRINCE FARMA SA.
This geographic spread reflects Soframycin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
Comprehensive geographic market intelligence dashboard
Trade flow of Soframycin exports from India — top destination countries and the named companies importing it
Top Countries → Global Importers
Sri Lanka ranks as the first-largest destination for Soframycin imports from India, with a total trade value of $473.2K across 16 shipments — representing a 79.0% share of all Soframycin exports. The average shipment value of $29.6K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Soframycin importers in Sri Lanka: A. BAUR & CO. (PVT.) LTD is the largest buyer, accounting for 44.0% ($208.0K) of this market's total imports.
• A. BAUR & CO. (PVT.) LTD — $208.0K (44.0% of Sri Lanka's total)
• A BAUR CO PRIVATE LIMITED — $168.8K (35.7% of Sri Lanka's total)
• A BAUR AND CO PVT LTD — $96.4K (20.4% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $29.6K (1100% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Soframycin imports from India.
Latest developments and market context
Detailed market intelligence for Soframycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
CAPSTONE EXPORT & IMPORT serves 1 named buyer in our database. PRINCE FARMA SA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• PRINCE FARMA SA — $70.0K across 10 shipments (100.0% of this supplier's total exports)
Key Insight: CAPSTONE EXPORT & IMPORT's per-shipment value of $7.0K is 184% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
S. HIMATLAL HEALTHCARE LLP is the third-largest Soframycin exporter from India, with a market share of 3.1% and a total export value of $18.5K across 16 shipments. Their average shipment value of $1.2K is below the market average of $2.5K, reflecting a high-volume, competitive pricing strategy.
S. HIMATLAL HEALTHCARE LLP serves 2 named buyers in our database. VMK MEDICAL ENTERPRISES is the dominant customer, accounting for 99.5% of this supplier's tracked business. Top customers include:
• VMK MEDICAL ENTERPRISES — $18.4K across 16 shipments (99.5% of this supplier's total exports)
• NA — $98 across 0 shipments (0.5% of this supplier's total exports)
Key Insight: S. HIMATLAL HEALTHCARE LLP operates with high shipment frequency (16 shipments) at a per-shipment value of $1.2K, indicating a broad distribution network with many smaller, regular orders.
VEA IMPEX (I) PRIVATE LIMITED is the fourth-largest Soframycin exporter from India, with a market share of 1.8% and a total export value of $10.6K across 14 shipments. Their average shipment value of $755 is below the market average of $2.5K, reflecting a high-volume, competitive pricing strategy.
VEA IMPEX (I) PRIVATE LIMITED serves 2 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 89.2% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $9.4K across 12 shipments (89.2% of this supplier's total exports)
• TO THE ORDER OF — $1.1K across 2 shipments (10.8% of this supplier's total exports)
Key Insight: VEA IMPEX (I) PRIVATE LIMITED operates with high shipment frequency (14 shipments) at a per-shipment value of $755, indicating a broad distribution network with many smaller, regular orders.
LINCOLN PHARMACEUTIC is the fifth-largest Soframycin exporter from India, with a market share of 0.6% and a total export value of $3.7K across 2 shipments. Their average shipment value of $1.9K is below the market average of $2.5K, reflecting a high-volume, competitive pricing strategy.
LINCOLN PHARMACEUTIC serves 1 named buyer in our database. UNGUJA PHARMACY LTD is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• UNGUJA PHARMACY LTD — $3.7K across 2 shipments (100.0% of this supplier's total exports)
Key Insight: LINCOLN PHARMACEUTIC operates with high shipment frequency (2 shipments) at a per-shipment value of $1.9K, indicating a broad distribution network with many smaller, regular orders.
NU HOSPITALS PRIVATE LIMITED is the fifth-largest Soframycin exporter from India, with a market share of 0.5% and a total export value of $3.2K across 3 shipments. Their average shipment value of $1.1K is below the market average of $2.5K, reflecting a high-volume, competitive pricing strategy.
NU HOSPITALS PRIVATE LIMITED serves 1 named buyer in our database. RIDHWAN & COMPANY is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• RIDHWAN & COMPANY — $3.2K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: NU HOSPITALS PRIVATE LIMITED operates with high shipment frequency (3 shipments) at a per-shipment value of $1.1K, indicating a broad distribution network with many smaller, regular orders.
Angola ranks as the second-largest destination for Soframycin imports from India, with a total trade value of $70.0K across 2 shipments — representing a 11.7% share of all Soframycin exports. The average shipment value of $35.0K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Soframycin importers in Angola: PRINCE FARMA SA is the largest buyer, accounting for 100.0% ($70.0K) of this market's total imports.
• PRINCE FARMA SA — $70.0K (100.0% of Angola's total)
Key Insight: Angola's per-shipment average of $35.0K (1321% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Angola is a key market for Soframycin imports from India.
Tanzania ranks as the third-largest destination for Soframycin imports from India, with a total trade value of $23.4K across 2 shipments — representing a 3.9% share of all Soframycin exports. The average shipment value of $11.7K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Soframycin importers in Tanzania: RIDHWAN & COMPANY is the largest buyer, accounting for 25.9% ($6.1K) of this market's total imports.
• RIDHWAN & COMPANY — $6.1K (25.9% of Tanzania's total)
Key Insight: Tanzania's per-shipment average of $11.7K (375% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tanzania is a key market for Soframycin imports from India.
Seychelles ranks as the fourth-largest destination for Soframycin imports from India, with a total trade value of $22.7K across 3 shipments — representing a 3.8% share of all Soframycin exports. The average shipment value of $7.6K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Soframycin importers in Seychelles: VMK MEDICAL ENTERPRISES is the largest buyer, accounting for 81.6% ($18.5K) of this market's total imports.
• VMK MEDICAL ENTERPRISES — $18.5K (81.6% of Seychelles's total)
Key Insight: Seychelles's per-shipment average of $7.6K (207% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Seychelles is a key market for Soframycin imports from India.
Zambia ranks as the fifth-largest destination for Soframycin imports from India, with a total trade value of $2.2K across 0 shipments — representing a 0.4% share of all Soframycin exports. The average shipment value of $2.2K is below the global average of $2.5K, consistent with generic/API volume purchasing.
Key Insight: Zambia receives frequent, smaller shipments of Soframycin — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Zambia is a key market for Soframycin imports from India.
Top supplier: 3 customers
6 suppliers → 36 countries
Network value: $598.8K
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
243 Verified Shipments
63 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists